← Eichor
Study identifier: NCT07705698 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Nordic vs Blood Flow Restriction Nordic Exercise in Elite Female Pole Vaulters

Condition: Muscle Strength · Athletic Performance · Hamstring Adaptation  ·  Sponsor: Toros University

PhaseNA
Planned participants36
Who can joinFemale, 12 Years to 18 Years
Healthy volunteersYes

About this study

The purpose of this randomized controlled trial is to compare the effects of Nordic Hamstring Exercise (NHE) and Blood Flow Restriction-assisted Nordic Hamstring Exercise (BFR-NHE) on hamstring muscle strength, muscle morphology, and functional performance in elite adolescent female pole vaulters. Thirty-six athletes aged 12-18 years will be randomly assigned to a Nordic Hamstring Exercise group, a Blood Flow Restriction-assisted Nordic Hamstring Exercise group, or a control group. Intervention groups will participate in supervised exercise training three times per week for eight weeks, while the control group will continue routine sports training. Outcomes will be assessed before and after the intervention period.

This description comes directly from the study's public registry record.

Talk to the study team

İdil Esin Ünlü, Assist. Prof. Dr.  ·  +90 506 515 66 22  ·  idil.unlu@toros.edu.tr

Always discuss trial participation with your own doctor first.

Locations (1)

Adana Olympic Preparation CenterAdana, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07705698